Addex Therapeutics ADXN
NASDAQ ADXN
$2.96 +0.22 (+8.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Addex Therapeutics (ADXN) Equity Income (2024 - 2026)

Updated

Addex Therapeutics (ADXN) reported Equity Income of -$1.57 million for Q1 2026, compared with -$943,188 a year earlier.

Analysis

Addex Therapeutics (ADXN) Equity Income (2024 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Addex Therapeutics' Equity Income came in at -$5.48 million; for FY2025, it came in at -$5.02 million.

  • By year, Equity Income came in at -$2.47 million in FY2024.
  • The Q1 2026 figure ranks as the lowest quarterly Equity Income in data going back to Q2 2024.
  • Per Business Quant data, the three quarters before Q1 2026 came in at -$1.32 million (Q4 2025), -$1.1 million (Q3 2025) and -$1.49 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -19.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Addex Therapeutics 3.65 Mn -3.31 Mn - -1.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.39 Mn
Mar 31, 2026 -1.57 Mn
Dec 31, 2025 -1.32 Mn
Sep 30, 2025 -1.10 Mn
Jun 30, 2025 -1.49 Mn
Mar 31, 2025 -942,577.83
Dec 31, 2024 -880,655.57
Sep 30, 2024 -1.01 Mn
Jun 30, 2024 -586,898.79
API Access

Addex Therapeutics Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ADXN&period=max&api_key=YOUR_API_KEY